Hong Kong stocks fluctuate | SHANDONG XINHUA (00719) AH Stocks have both dropped over 6%, having previously strengthened for two consecutive Trade days.

SHANDONG XINHUA (00719) AH Stocks have fallen by over 6%, after experiencing two consecutive days of strength. As of the time of writing, A Shares have decreased by 6.24%, and H Shares have fallen by 6.76%, trading at 5.93 Hong Kong dollars, with a transaction value of 51.139 million Hong Kong dollars.

Zhitong FinanceJan 6 21:58 ET

Pharmaceutical stocks have become a transitional theme at present, and the performance line may be further valued by the market.

Track the entire lifecycle of the main sector.

cls.cnJan 6 20:20 ET

SHANDONG XINHUA (00719): Stocks Trade shows abnormal fluctuations; there is no significant information that should be disclosed but has not been disclosed.

SHANDONG XINHUA (00719) announced that the company's A-shares will be available on January 3, 2025, and January 6, 2025...

Zhitong FinanceJan 6 04:13 ET

Hong Kong stocks movement | SHANDONG XINHUA (00719) rose over 10%, the company's A-shares hit the price limit, driven by a surge in sales of related drugs due to high incidence of influenza.

SHANDONG XINHUA (00719) rises over 10%, the company's A-shares have hit the daily limit. As of the time of writing, it has increased by 10.27%, priced at 6.23 Hong Kong dollars, with a transaction volume of 81.8506 million Hong Kong dollars.

Zhitong FinanceJan 2 21:07 ET

Shandong Xinhua Pharmaceutical to Renew License Agreement for Trademark Xinhua

MT NewswiresDec 31, 2024 05:48 ET

How is the quality and supply of Pharmaceuticals guaranteed? The National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals.

On December 26, 2024, the National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals, inviting representatives from the National Medical Products Administration, selected Pharmaceutical enterprises, and research Institutions to communicate and exchange views on recent societal concerns regarding quality assurance of centrally procured Pharmaceuticals and innovative development in the Industry, and to listen to opinions and suggestions.

Zhitong FinanceDec 30, 2024 00:32 ET